Je was op zoek naar: ciklofosfamidu (Lithouws - Engels)

busilvex skyrimas kartu su ciklofosfamidu:
busilvex in combination with cyclophosphamide:

vaistas yra vartojamas derinyje su ciklofosfamidu.
the recommended dose of busilvex is 0.8 mg per kg of body weight, in combination with cyclophosphamide.

vartojamas kartu su doksorubicinu ir ciklofosfamidu;
administered in combination with doxorubicin and cyclophosphamide.

busilvex skyrimas kartu su ciklofosfamidu arba melfalanu
busilvex in combination with cyclophosphamide or melphalan

busulfan fresenius kabi skyrimas kartu su ciklofosfamidu:
busulfan fresenius kabi in combination with cyclophosphamide:

busilvex vartojimas kartu su ciklofosfamidu arba melfalanu suaugusiems
busilvex in combination with cyclophosphamide or melphalan in adults

siuo atveju abu vaistai buvo skiriami kartu su ciklofosfamidu.
in all three studies, the main measure of effectiveness was the proportion of patients who had responded to treatment after six weeks.

iš viso 714 pacientai (99,9 %) buvo gydomi ciklofosfamidu.
a total of 724 patients (99.9%) were treated with cyclophosphamide.

busulfan fresenius kabi vartojimas kartu su ciklofosfamidu arba melfalanu suaugusiems
busulfan in combination with cyclophosphamide or melphalan in adults

suaugusiems busulfan fresenius kabi vartojamas kartu su ciklofosfamidu arba fludarabinu.
in adults busulfan fresenius kabi is used in combination with cyclophosphamide or fludarabine.

citotoksiniais vaistais (vartojamais vėžiui gydyti), pavyzdžiui, metotreksatu ar ciklofosfamidu;
cytotoxic medicines (used to treat cancer), such as methotrexate or cyclophosphamide;

citotoksiniai preparatai (pvz., ciklofosfamidas, metotreksatas)
cytotoxic agents (e.g. cyclophosphamide, methotrexate)